Maze Therapeutics, Inc. Common Stock (MAZE) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.
MAZE has 6 Form 4 insider filings recorded at the SEC in the past 30 days[1].
Sources
- SEC EDGAR · 0001842295 (2026-04-11) ↗